The drug can now be used to treat locally advanced head and neck cancer prior to chemoradiotherapy and surgery, Sanofi-Aventis said in a statement.
Advanced clinical trials showed that using Taxotere in combination with standard induction chemotherapy resulted in a more than three year improvement in patient survival rate, the company said.
More than 640,000 people worldwide are diagnosed with head and neck cancer each year, and more than 350,000 die from the disease annually, the company said.
Sanofi-Aventis' shares were down 0.1 percent at EUR59.33 (US$84.12) in Paris.
Why should Netanyahu be a friend of Russia? Benjamin Netanyahu is the Prime Minister of the State of Israel. He defends the national interests of the State of Israel
When General Wesley Clark spoke about the famous list of seven Middle Eastern countries to be demolished in five consecutive years, he has done nothing but remark, for the last time, if there was any need, Washington's willingness to redesign the Middle East within a more general framework of global domination.